Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis.

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

July 1, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

March 31, 2024

Conditions

Vulvovaginal Candidiasis

Interventions

DRUG

Venus 20 + 0,064

Venus vaginal cream 20 + 0,064, single-dose.

DRUG

Venus 20 + 1

Venus vaginal cream 20 + 1, single-dose.

DRUG

Venus 20 + 4

Venus vaginal cream 20 + 4, single-dose.

DRUG

Butoconazole nitrate

Butoconazole nitrate vaginal cream, 100 mg single-dose.